Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 902,802 |
|
|||||
| News | - | ||||||
| Day High | 40.74 | Low High |
|||||
| Day Low | 39.79 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Halozyme Therapeutics Incorporated | HALO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.09 | 0.23% | 39.91 | 23:00:06 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 40.67 | 39.79 | 40.74 | 39.91 | 39.82 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 16,217 | 902,802 | US$ 40.29 | US$ 36,373,893 | - | 29.85 - 45.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:37:06 | 1 | US$ 40.69 | USD |
Halozyme Therapeutics (HALO) Options Flow Summary
Halozyme Therapeutics Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.06B | 126.82M | - | 829.25M | 281.59M | 2.22 | 17.98 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Halozyme Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HALO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 38.46 | 40.74 | 37.965 | 38.94 | 812,397 | 1.45 | 3.77% |
| 1 Month | 39.80 | 41.50 | 37.73 | 39.09 | 866,824 | 0.11 | 0.28% |
| 3 Months | 35.38 | 42.64 | 34.36 | 39.43 | 997,384 | 4.53 | 12.80% |
| 6 Months | 34.92 | 42.82 | 33.15 | 37.80 | 1,172,641 | 4.99 | 14.29% |
| 1 Year | 31.98 | 45.00 | 29.85 | 37.64 | 1,081,813 | 7.93 | 24.80% |
| 3 Years | 50.43 | 59.46 | 29.85 | 41.08 | 1,100,280 | -10.52 | -20.86% |
| 5 Years | 16.50 | 59.46 | 12.71 | 34.83 | 1,198,341 | 23.41 | 141.88% |
Halozyme Therapeutics Description
| Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. |
